The Venture Codex Logo

The Venture Codex

Charles River Laboratories

251 Ballardvale Street, Wilmington, MA, 01887, United States

Overview

Solutions for accelerating drug discovery and development processes.

Founded

1947

Deals · 12mo

0

Links

WebsiteLinkedInX (Twitter)

Stage focus

Seed
Series A
Series B

Geographic focus

Canada
France
Ireland
United Kingdom
...

Sector focus

Biotechnology
Health Care
Pharmaceutical

Investment portfolio

10rounds
NAMEDATESIZE
Deciphex
Jan 2025Participated
$36 MSeries C
Ability biologics
Jun 2024Participated
$18 MSeed
Ability biologics
Dec 2023Participated
$12 MSeed
Vernal Biosciences
Jun 2023Led
$20 MOther Equity
Wheeler Bio
Apr 2023Led
$31 MSeries A
iVexSol
Jan 2023Participated
$24 MSeries A
Vernal Biosciences
Jun 2022Participated
$21 MOther Equity
Deciphex
May 2022Participated
$12 MSeries B
bit.bio
Nov 2021Participated
$103 MSeries B
PathoQuest
Sep 2019Participated
$9 MOther Equity
Deciphex
Jan 2025Participated
$36 MSeries C
Ability biologics
Jun 2024Participated
$18 MSeed
Ability biologics
Dec 2023Participated
$12 MSeed
Vernal Biosciences
Jun 2023Led
$20 MOther Equity
Wheeler Bio
Apr 2023Led
$31 MSeries A
iVexSol
Jan 2023Participated
$24 MSeries A
Vernal Biosciences
Jun 2022Participated
$21 MOther Equity
Deciphex
May 2022Participated
$12 MSeries B
bit.bio
Nov 2021Participated
$103 MSeries B
PathoQuest
Sep 2019Participated
$9 MOther Equity
10
Items
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

Charles River Laboratories: 10 funding rounds are recorded in the selected participation categories.All available history.
Charles River Laboratories: 10 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Seed02
Series A11
Series B02
Series C+01
Other Equity12

Monthly Deal Activity

Charles River Laboratories: 10 deals are recorded across 86 months.All available history.
Charles River Laboratories: 10 deals are recorded across 86 months. All available history
MonthDeals
Sep '191
Oct '190
Nov '190
Dec '190
Jan '200
Feb '200
Mar '200
Apr '200
May '200
Jun '200
Jul '200
Aug '200
Sep '200
Oct '200
Nov '200
Dec '200
Jan '210
Feb '210
Mar '210
Apr '210
May '210
Jun '210
Jul '210
Aug '210
Sep '210
Oct '210
Nov '211
Dec '210
Jan '220
Feb '220
Mar '220
Apr '220
May '221
Jun '221
Jul '220
Aug '220
Sep '220
Oct '220
Nov '220
Dec '220
Jan '231
Feb '230
Mar '230
Apr '231
May '230
Jun '231
Jul '230
Aug '230
Sep '230
Oct '230
Nov '230
Dec '231
Jan '240
Feb '240
Mar '240
Apr '240
May '240
Jun '241
Jul '240
Aug '240
Sep '240
Oct '240
Nov '240
Dec '240
Jan '251
Feb '250
Mar '250
Apr '250
May '250
Jun '250
Jul '250
Aug '250
Sep '250
Oct '250
Nov '250
Dec '250
Jan '260
Feb '260
Mar '260
Apr '260
May '260
Jun '260
Jul '260
Aug '260
Sep '260
Oct '260

Sector Breakdown

Charles River Laboratories: Health & Life Sciences is the largest displayed sector by deal count (9 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

Charles River Laboratories: Health & Life Sciences is the largest displayed sector by deal count (9 deals). All available history
SectorDeals
Health & Life Sciences9
AI & Machine Learning2
Networks, Cloud & Communication1
Manufacturing1

Deal Size Distribution

Charles River Laboratories: 10 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

Charles River Laboratories: 10 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M0
$5M-$10M1
$10M-$25M6
$25M-$50M2
$50M-$100M0
$100M-$250M1
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

Charles River Laboratories: United States has the largest recorded deal count among the displayed regions (4 deals).All available history.

Top 3 of 3 regions; European countries are grouped as Europe.

Charles River Laboratories: United States has the largest recorded deal count among the displayed regions (4 deals). All available history
RegionDeals
United States4
Europe4
Canada2
Charles River Laboratories: 20 co-investors are shown, with Act Venture Capital sharing 2 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Charles River Laboratories: 20 co-investors are shown, with Act Venture Capital sharing 2 recorded deals. All available history
Co-investorShared deals
Act Venture Capital2
Alexandria Venture Investments2
Alloy Therapeutics2
Ampersand Capital Partners2
Amplitude Ventures2
ATUM2
Dynamk Capital2
Fonds de solidarit FTQ2
HBAN Medtech Syndicate2
Irrus Investments2
Nextsteps Capital2
ARCH Venture Partners1
Asahi Kasei Medical1
BioLife Solutions1
Bristol Myers Squibb1
Casdin Capital1
Echo1
Floating Point1
Foresite Capital1
Idinvest Partners1

Investment Strategy

Charles River Laboratories: Led accounts for 20% and participating for 80% of round participation.All available history.
Charles River Laboratories: Led accounts for 20% and participating for 80% of round participation. All available history
CategoryDeals (count)Share (%)
Led220%
Participating880%
Charles River Laboratories: Single-lead accounts for 0% and co-led for 100% of lead dynamics.All available history.
Charles River Laboratories: Single-lead accounts for 0% and co-led for 100% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead00%
Co-led2100%

Team

Anja Tessarz

Scientific Specialist Viral Clearance

Chris Lowrie

Senior Director, Lab Sciences

Gina Mullane

Sr. Vice President Client Experience and Chief Marketing Officer

Greg Mason

Sr. Director, Global Category Procurement, Lab Operations

Jacob McDaniel

Director of Experience Design

Tiffany Granacki

Director, Sales and Marketing

Virginia M. Wilson

Director

William D. Barbo

Executive Vice President & Chief Commercial Officer